4//SEC Filing
Vandervoort Adam C 4
Accession 0001477449-25-000083
CIK 0001477449other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:37 PM ET
Size
15.9 KB
Accession
0001477449-25-000083
Insider Transaction Report
Form 4
Vandervoort Adam C
CHIEF LEGAL OFFICER, SECRETARY
Transactions
- Sale
Common Stock
2025-06-02$6.86/sh−5,808$39,843→ 69,773 total - Exercise/Conversion
Restricted Stock Units
2025-05-30−5,350→ 37,450 total→ Common Stock (5,350 underlying) - Exercise/Conversion
Performance Stock Units
2025-05-30−1,505→ 4,520 total→ Common Stock (1,505 underlying) - Exercise/Conversion
Restricted Stock Units
2025-05-30−4,418→ 13,254 total→ Common Stock (4,418 underlying) - Exercise/Conversion
Common Stock
2025-05-30+4,418→ 70,231 total - Exercise/Conversion
Common Stock
2025-05-30+1,505→ 65,813 total - Exercise/Conversion
Common Stock
2025-05-30+5,350→ 75,581 total
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Documents
Issuer
Teladoc Health, Inc.
CIK 0001477449
Entity typeother
Related Parties
1- filerCIK 0001375088
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:37 PM ET
- Size
- 15.9 KB